Covidh Technologies
add_icon

Covidh Technologies

74.16
-74.16
(-100.00%)
Market Cap
62.40 Cr
PE Ratio
-1,059.43
Volume
0.00
Day High - Low
74.16 - 74.16
52W High-Low
74.16 - 1.90
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
62.40 Cr
EPS
-0.04
PE Ratio
-1,059.43
PB Ratio
7.82
Book Value
9.49
EBITDA
0.50
Dividend Yield
0.00 %
Return on Equity
-8.82
Debt to Equity
19.95
Forecast For
Actual

Company News

View All News
Caret
neutral
iSERA Lifesciences Limited submits newspaper advertisement for postal ballot notice to BSE under Regulation 30, with remote e-voting commencing April 22, 2026.
neutral
iSERA Lifesciences Limited has scheduled a Board meeting on April 20, 2026, to consider and approve preferential issue of equity shares on private placement basis along with other business matters.
neutral
Covidh Technologies Limited officially renamed to iSERA Lifesciences Limited with MCA approval effective April 10, 2026, following shareholder approval through special resolution.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,488.00
#1 9,00,180.17
18.45
#1 2,71,423.00
4.68
#1 49,454
12.13
48.29
1,200.00
4,86,646.94
18.00
1,66,590.00
5.18
26,750
20.90
37.16
1,264.40
3,43,115.81
20.81
1,30,144.00
8.87
16,997
4.20
31.42
202.75
2,12,646.72
#1 16.04
92,624.00
-0.37
13,076
-1.85
50.64
1,407.10
1,37,864.80
28.96
56,815.40
5.52
4,571
18.78
45.38
4,440.00
1,31,643.03
28.37
38,997.80
7.67
4,602
22.92
49.63
5,048.00
79,632.20
42.76
14,748.50
22.12
1,814
#1 33.73
43.99
2,266.00
43,239.71
24.15
14,485.00
7.33
1,702
3.37
47.35
1,211.00
40,665.41
37.84
12,215.40
#1 34.91
964
15.94
47.44
466.30
28,491.68
20.70
13,818.70
14.68
1,368
-9.07
46.52
Growth Rate
Revenue Growth
-23.51 %
Net Income Growth
-
Cash Flow Change
49.23 %
ROE
-721.13 %
ROCE
22.74 %
EBITDA Margin (Avg.)
32.62 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Revenue
2
4
6
14
10
7
4
4
1
Expenses
2
4
6
14
10
7
4
3
1
EBITDA
1
0
0
0
0
0
0
0
0
Operating Profit %
27 %
3 %
3 %
2 %
1 %
1 %
2 %
6 %
-1 %
Depreciation
1
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
0
0
0
-0
Tax
0
0
0
0
0
0
0
0
0
Net Profit
0
0
0
0
0
0
0
0
-0
EPS in ₹
0.06
0.07
0.09
0.00
0.02
0.00
-0.01
-0.03
-0.06

Balance Sheet

Balance Sheet
2015
2016
2018
2019
Total Assets
25
15
20
18
Fixed Assets
8
1
1
1
Current Assets
12
14
19
17
Capital Work in Progress
4
0
0
0
Investments
0
0
0
0
Other Assets
13
14
19
17
Total Equity & Liabilities
25
15
20
18
Current Liabilities
5
8
12
9
Non Current Liabilities
6
6
8
8
Total Equity
14
1
1
1
Reserve & Surplus
3
-10
-10
-10
Share Capital
11
11
11
11

Cash Flow

Cash Flow
2015
2016
2018
2019
Net Cash Flow
0
0
0
0
Investing Activities
-1
-0
-0
-0
Operating Activities
1
1
-1
-0
Financing Activities
1
-0
1
1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Nov 2025
Dec 2025
Mar 2026
Promoter
26.35 %
26.35 %
26.35 %
26.35 %
26.35 %
100.00 %
100.00 %
100.00 %
100.00 %
100.00 %
100.00 %
26.35 %
26.35 %
26.35 %
26.35 %
26.35 %
92.76 %
92.76 %
92.76 %
3.57 %
3.57 %
58.63 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
72.04 %
70.37 %
70.37 %
70.37 %
70.37 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
70.81 %
70.81 %
70.81 %
70.81 %
70.81 %
6.91 %
6.91 %
6.91 %
91.69 %
91.10 %
35.70 %
Others
1.61 %
3.28 %
3.28 %
3.28 %
3.28 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.84 %
2.84 %
2.84 %
2.84 %
2.84 %
0.33 %
0.33 %
0.34 %
4.75 %
5.34 %
5.67 %
No of Share Holders
2,452
2,465
2,500
2,500
2,500
1
1
1
1
1
1
2,530
2,530
2,530
2,530
2,530
932
932
936
1,031
1,034
1,029

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 2.03 2.03
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 2.03 2.03
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 2.03 2.03
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 2.03 2.03
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 3.47 3.88
26 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Aug 2025 3.88 5.21
24 Oct 2025 RIGHTS Rights
25:1
24 Oct 2025 9.73 9.92
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 8.30 8.79
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 27.17 28.82
02 Apr 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
02 Apr 2026 41.86 56.26

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot2 days ago
Revised Outcome Of The Meeting Of The Board Of Directors Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) (The Company) Pursuant To Regulation 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations2 days ago
Announcement under Regulation 30 (LODR)-Preferential Issue2 days ago
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association2 days ago
Announcement under Regulation 30 (LODR)-Acquisition2 days ago
Announcement under Regulation 30 (LODR)-Raising of Funds2 days ago
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) (The Company)2 days ago
Board Meeting Outcome for Intimation Of Deferment Of Board Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) Scheduled On Monday April 20 2026.3 days ago
Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1)(D) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 20158 days ago
Announcement under Regulation 30 (LODR)-Change of Company NameApr 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 03, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 02, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMApr 02, 2026
Closure of Trading WindowMar 27, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 12, 2026
Extra-Ordinary General Meeting (Hereinafter Referred To As EGM) Of The Members Of Covidh Technologies Limited Will Be Held On Thursday 2Nd Day Of April 2026 At 12:00 P.M. Through Video Conferencing (VC) / Other Audio Visual Means(OAVM)Mar 11, 2026
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMar 10, 2026
Outcome Of The Meeting Of The Board Of Directors Of Covidh Technologies Limited Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 10, 2026
Board Approval For Change Of NameMar 10, 2026
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMar 10, 2026
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Covidh Technologies Limited Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 10, 2026
Announcement under Regulation 30 (LODR)-AcquisitionFeb 23, 2026
Announcement under Regulation 30 (LODR)-AcquisitionFeb 23, 2026
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressFeb 16, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Results-Financial Results For Quarter Ended 31.12.2025Feb 10, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 10Th February 2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 10, 2026
Update On The Shifting Of The Registered Office From One State To AnotherFeb 09, 2026
Update On The Shifting Of The Registered Office Of The CompanyFeb 05, 2026
Board Meeting Intimation for Prior Intimation Of The Board Meeting To Consider The Un-Audited Financial Results (Standalone) Of The Company For The Quarter Ended 31St December 2025 Under Regulation 29 Of The SEBI (LODR) Regulations 2015.Feb 05, 2026
Post-Offer AdvertisementJan 28, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Closure of Trading WindowDec 27, 2025
Pre-offer Advertisement and Corrigendum to the Detailed Public StatementDec 22, 2025
Recommendations of the Committee of ID under Reg 26(7) of SEBI (SAST) Regulations 2011Dec 19, 2025
Letter of OfferDec 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Nov 14, 2025
Non-Applicability Ff Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 30Th September 2025.Nov 13, 2025
Un-Audited Financials Results For The Quarter And Half Year Ended 30.09.2025Nov 13, 2025
Board Meeting Outcome for For Approving The Enclosed AgendasNov 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Announcement under Regulation 30 (LODR)-AllotmentNov 11, 2025
Board Meeting Outcome for Board Meeting Outcome For Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations) For Allotment Of Equity Shares On Rights BasisNov 11, 2025
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2025Nov 10, 2025
Intimation Pursuant To Regulation 77B(2) Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018 Regarding Applications Submitted By Specific Investors Under The Rights IssueNov 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2025

Technical Indicators

RSI(14)
Overbought
100.00
ATR(14)
Less Volatile
1.16
STOCH(9,6)
Overbought
100.00
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.54
ADX(14)
Extremely Strong Trend
99.87
UO(9)
Bearish
100.00
ROC(12)
Uptrend And Accelerating
26.73
WillR(14)
Overbought
0.00